Replies to post #36910 on Elite Pharmaceuticals Inc (ELTP)

[DR Ryan]

We sure think so. Lots of Homeruns on this list that could happen at any time!

Breakdown of Known Upcoming Catalysts

Naltrexone Approval and then Launch
Undisclosed Opioid ANDA – 80m generic – Approval and then Launch
Phendimetrazine ANDA Approval and then Launch
Approval of second Manufacturing Facility
New Financing deal
Approval of Epics first of 8 products
Additional Opioid ANDA is pending approval
Patent Pending Approval - 12/640,344 – Abuse resistance
Patent Pending Approval - 13/379,486 – Micro-Tabets - .25mm – 1mm – All types of medications
Patent Pending Approval - 13/379,481 – Use of the Micro-tablets to make abuse resistant products
Approval and Launch of HITKs generic of a 100m branded product
Approval and Launch of MIK001
Approval and Launch of HK Pharma product
Return of Lodrane
2nd Quarter revenue will show ~200% increase over the previous year
Profitability – Elite expects to hit cash flow neutral/positive in the 4th quarter this year.
Anything to do with a sale of Novel Labs – Elite Owns 10%
Anything to do with the closing of Elite’s debt issue with NJEDA

[Drugdoctor]

Welcome to the board A-train... it does look really bright for ELTP and its investors in 2013